Middle East & Africa In-Vitro Lung Model Market Size and Forecast (2021 - 2031)
The Middle East & Africa In-Vitro Lung Model Market is projected to grow significantly, reaching an estimated US$ 30.6 million by 2031, up from US$ 9.7 million in 2024. This growth reflects a compound annual growth rate (CAGR) of 18.1% from 2025 to 2031, driven by various factors including the rising prevalence of respiratory diseases and advancements in healthcare infrastructure.
Executive Summary and Market Analysis
The in vitro lung model market in the Middle East & Africa is categorized into several regions, including the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. The increasing incidence of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and lung cancer has created a heightened demand for reliable preclinical models. In vitro lung models provide controlled environments that facilitate the study of disease mechanisms, drug responses, and potential treatments, addressing the urgent need for effective solutions in respiratory health.
Additionally, the growing elderly population, advancements in healthcare infrastructure, and a strong emphasis on ethical research practices are contributing to the market's expansion. The reduction of animal testing in scientific studies is also accelerating the adoption of in vitro models, as researchers seek more humane and effective alternatives.
Strategic Insights
Market Segmentation Analysis
The Middle East & Africa In-Vitro Lung Model Market is segmented by type, application, and end user:
Two-dimensional (2D) cell cultures, commonly used in cellular biology for disease study and drug screening, are cost-effective and easy to replicate. However, they fail to accurately mimic the complex tumor microenvironment (TME) found in living organisms, which limits their effectiveness in modeling cancer behavior and drug responses. As cancer research progresses, there is a growing reliance on animal models, which, despite their use, often show low success rates in translating preclinical findings into clinical treatments. This has raised concerns about their reliability in predicting human responses.
To overcome these limitations, there is a shift towards more physiologically relevant human in vitro models, particularly 3D cell culture systems such as spheroids, organoids, tumoroids, and microfluidic systems. These models more accurately mimic the TME, gene expression, and drug responses observed in clinical settings, making them essential for validating drug efficacy and enhancing preclinical testing, especially in lung cancer research.
The integration of 3D models into high-throughput drug screening presents challenges, particularly in automating analysis systems. However, the incorporation of artificial intelligence (AI) and machine learning (ML) into the analysis of 3D models holds significant promise. These technologies can enhance predictive accuracy, automate data processing, and optimize experimental design, allowing researchers to gain deeper insights into tumor biology and progression, personalize treatments, and reduce reliance on animal testing.
Compared to traditional 2D cultures and animal models, 3D models provide superior physiological relevance, making them vital tools for preclinical testing and personalized medicine. By leveraging ML and AI, researchers can extract complex, multidimensional data from these 3D culture systems, improving their accuracy in mimicking human tumor biology. This technological advancement represents a transformative shift in cancer drug development, paving the way for more effective and individualized therapies.
Country Insights
The market is further segmented by country, with Saudi Arabia, South Africa, the United Arab Emirates, and the Rest of the Middle East & Africa. Saudi Arabia held the largest market share in 2024. The prevalence of chronic obstructive pulmonary disease (COPD) in Saudi Arabia has risen significantly, with a 49% increase in age-standardized prevalence from 1990 to 2019. This alarming trend has intensified the demand for advanced research models, as in vitro lung models provide a cost-effective and ethical alternative to animal testing, enabling more efficient studies of disease mechanisms and therapeutic interventions.
Saudi Arabia's Vision 2030 initiative emphasizes healthcare innovation, leading to increased investments in medical research and infrastructure. Institutions like the King Faisal Specialist Hospital and Research Centre and the King Abdullah International Medical Research Center are at the forefront of biomedical research, particularly in respiratory diseases, and are promoting the development of in vitro models.
Company Profiles
Key players in the Middle East & Africa In-Vitro Lung Model Market include Charles River Laboratories International Inc, Lonza Group AG, Merck KGaA, American Type Culture Collection (ATCC), Draper, Inc., PromoCell GmbH, Emulate, Inc., MIMETAS BV, Organovo Holdings Inc, MatTek Corp, CN Bio Innovations Ltd, InSphero AG, Epithelix, AlveoliX AG, and TissUse GmbH. These companies are pursuing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products to consumers.
Executive Summary and Market Analysis
The in vitro lung model market in the Middle East & Africa is categorized into several regions, including the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. The increasing incidence of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and lung cancer has created a heightened demand for reliable preclinical models. In vitro lung models provide controlled environments that facilitate the study of disease mechanisms, drug responses, and potential treatments, addressing the urgent need for effective solutions in respiratory health.
Additionally, the growing elderly population, advancements in healthcare infrastructure, and a strong emphasis on ethical research practices are contributing to the market's expansion. The reduction of animal testing in scientific studies is also accelerating the adoption of in vitro models, as researchers seek more humane and effective alternatives.
Strategic Insights
Market Segmentation Analysis
The Middle East & Africa In-Vitro Lung Model Market is segmented by type, application, and end user:
- By Type: The market is divided into 3D Models and 2D Models. In 2024, 3D Models held the largest market share due to their ability to better replicate the complex interactions found in living tissues compared to traditional 2D models.
- By Application: The market is segmented into Drug Discovery and Toxicology Studies, Physiological Research, Regenerative Medicine, and Others. Drug Discovery and Toxicology Studies accounted for the largest share in 2024, reflecting the critical role of in vitro models in the pharmaceutical industry.
- By End User: The market is categorized into Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others. Pharmaceutical and Biotechnology Companies dominated the market in 2024, driven by their need for effective preclinical testing models.
Two-dimensional (2D) cell cultures, commonly used in cellular biology for disease study and drug screening, are cost-effective and easy to replicate. However, they fail to accurately mimic the complex tumor microenvironment (TME) found in living organisms, which limits their effectiveness in modeling cancer behavior and drug responses. As cancer research progresses, there is a growing reliance on animal models, which, despite their use, often show low success rates in translating preclinical findings into clinical treatments. This has raised concerns about their reliability in predicting human responses.
To overcome these limitations, there is a shift towards more physiologically relevant human in vitro models, particularly 3D cell culture systems such as spheroids, organoids, tumoroids, and microfluidic systems. These models more accurately mimic the TME, gene expression, and drug responses observed in clinical settings, making them essential for validating drug efficacy and enhancing preclinical testing, especially in lung cancer research.
The integration of 3D models into high-throughput drug screening presents challenges, particularly in automating analysis systems. However, the incorporation of artificial intelligence (AI) and machine learning (ML) into the analysis of 3D models holds significant promise. These technologies can enhance predictive accuracy, automate data processing, and optimize experimental design, allowing researchers to gain deeper insights into tumor biology and progression, personalize treatments, and reduce reliance on animal testing.
Compared to traditional 2D cultures and animal models, 3D models provide superior physiological relevance, making them vital tools for preclinical testing and personalized medicine. By leveraging ML and AI, researchers can extract complex, multidimensional data from these 3D culture systems, improving their accuracy in mimicking human tumor biology. This technological advancement represents a transformative shift in cancer drug development, paving the way for more effective and individualized therapies.
Country Insights
The market is further segmented by country, with Saudi Arabia, South Africa, the United Arab Emirates, and the Rest of the Middle East & Africa. Saudi Arabia held the largest market share in 2024. The prevalence of chronic obstructive pulmonary disease (COPD) in Saudi Arabia has risen significantly, with a 49% increase in age-standardized prevalence from 1990 to 2019. This alarming trend has intensified the demand for advanced research models, as in vitro lung models provide a cost-effective and ethical alternative to animal testing, enabling more efficient studies of disease mechanisms and therapeutic interventions.
Saudi Arabia's Vision 2030 initiative emphasizes healthcare innovation, leading to increased investments in medical research and infrastructure. Institutions like the King Faisal Specialist Hospital and Research Centre and the King Abdullah International Medical Research Center are at the forefront of biomedical research, particularly in respiratory diseases, and are promoting the development of in vitro models.
Company Profiles
Key players in the Middle East & Africa In-Vitro Lung Model Market include Charles River Laboratories International Inc, Lonza Group AG, Merck KGaA, American Type Culture Collection (ATCC), Draper, Inc., PromoCell GmbH, Emulate, Inc., MIMETAS BV, Organovo Holdings Inc, MatTek Corp, CN Bio Innovations Ltd, InSphero AG, Epithelix, AlveoliX AG, and TissUse GmbH. These companies are pursuing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products to consumers.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. IN-VITRO LUNG MODEL MARKET LANDSCAPE
4.1 PEST Analysis
4.2 Regulatory Scenario
4.4 List of Vendors in the Value Chain
5. MIDDLE EAST & AFRICA IN-VITRO LUNG MODEL MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. IN-VITRO LUNG MODEL MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
6.1 Middle East & Africa In-Vitro Lung Model Market Revenue (US$ Million), 2024 - 2031
6.2 Middle East & Africa In-Vitro Lung Model Market Forecast and Analysis
7. MIDDLE EAST & AFRICA IN-VITRO LUNG MODEL MARKET REVENUE ANALYSIS - BY TYPE
7.1 3D Model
7.1.1 Overview
7.1.2 3D Model: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 2D Model
7.2.1 Overview
7.2.2 2D Model: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. MIDDLE EAST & AFRICA IN-VITRO LUNG MODEL MARKET REVENUE ANALYSIS - BY APPLICATION
8.1 Drug Discovery and Toxicology Studies
8.1.1 Overview
8.1.2 Drug Discovery and Toxicology Studies: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Physiological Research
8.2.1 Overview
8.2.2 Physiological Research: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Regenerative Medicine
8.3.1 Overview
8.3.2 Regenerative Medicine: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. MIDDLE EAST & AFRICA IN-VITRO LUNG MODEL MARKET REVENUE ANALYSIS - BY END USER
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Academic and Research Institutes
9.2.1 Overview
9.2.2 Academic and Research Institutes: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. MIDDLE EAST & AFRICA IN-VITRO LUNG MODEL MARKET - COUNTRY ANALYSIS
10.1 Middle East & Africa
10.1.1 Middle East & Africa In-Vitro Lung Model Market Revenue and Forecast and Analysis - by Country
10.1.1.1 Middle East & Africa In-Vitro Lung Model Market Revenue and Forecast and Analysis - by Country
10.1.2.2 Saudi Arabia: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 Saudi Arabia: Middle East & Africa In-Vitro Lung Model Market Share - by Type
10.1.2.2.2 Saudi Arabia: Middle East & Africa In-Vitro Lung Model Market Share - by Application
10.1.2.2.3 Saudi Arabia: Middle East & Africa In-Vitro Lung Model Market Share - by End User
10.2.3.3 South Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 South Africa: Middle East & Africa In-Vitro Lung Model Market Share - by Type
10.2.3.3.2 South Africa: Middle East & Africa In-Vitro Lung Model Market Share - by Application
10.2.3.3.3 South Africa: Middle East & Africa In-Vitro Lung Model Market Share - by End User
10.3.4.4 United Arab Emirates: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 United Arab Emirates: Middle East & Africa In-Vitro Lung Model Market Share - by Type
10.3.4.4.2 United Arab Emirates: Middle East & Africa In-Vitro Lung Model Market Share - by Application
10.3.4.4.3 United Arab Emirates: Middle East & Africa In-Vitro Lung Model Market Share - by End User
10.4.5.5 Rest of Middle East & Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa In-Vitro Lung Model Market Share - by Type
10.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa In-Vitro Lung Model Market Share - by Application
10.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa In-Vitro Lung Model Market Share - by End User
11 COMPETITIVE LANDSCAPE
11. GLOBAL COMPANY MARKET SHARE ANALYSIS, 2024
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 Charles River Laboratories International Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Lonza Group AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Merck KGaA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 American Type Culture Collection (ATCC)
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Draper, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 PromoCell GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Emulate, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 MIMETAS BV
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Organovo Holdings Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 MatTek Corp
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 CN Bio Innovations Ltd
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 InSphero AG
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Epithelix
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 AlveoliX AG
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 TissUse GmbH
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. IN-VITRO LUNG MODEL MARKET LANDSCAPE
4.1 PEST Analysis
4.2 Regulatory Scenario
4.4 List of Vendors in the Value Chain
5. MIDDLE EAST & AFRICA IN-VITRO LUNG MODEL MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. IN-VITRO LUNG MODEL MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
6.1 Middle East & Africa In-Vitro Lung Model Market Revenue (US$ Million), 2024 - 2031
6.2 Middle East & Africa In-Vitro Lung Model Market Forecast and Analysis
7. MIDDLE EAST & AFRICA IN-VITRO LUNG MODEL MARKET REVENUE ANALYSIS - BY TYPE
7.1 3D Model
7.1.1 Overview
7.1.2 3D Model: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 2D Model
7.2.1 Overview
7.2.2 2D Model: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. MIDDLE EAST & AFRICA IN-VITRO LUNG MODEL MARKET REVENUE ANALYSIS - BY APPLICATION
8.1 Drug Discovery and Toxicology Studies
8.1.1 Overview
8.1.2 Drug Discovery and Toxicology Studies: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Physiological Research
8.2.1 Overview
8.2.2 Physiological Research: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Regenerative Medicine
8.3.1 Overview
8.3.2 Regenerative Medicine: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. MIDDLE EAST & AFRICA IN-VITRO LUNG MODEL MARKET REVENUE ANALYSIS - BY END USER
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Academic and Research Institutes
9.2.1 Overview
9.2.2 Academic and Research Institutes: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. MIDDLE EAST & AFRICA IN-VITRO LUNG MODEL MARKET - COUNTRY ANALYSIS
10.1 Middle East & Africa
10.1.1 Middle East & Africa In-Vitro Lung Model Market Revenue and Forecast and Analysis - by Country
10.1.1.1 Middle East & Africa In-Vitro Lung Model Market Revenue and Forecast and Analysis - by Country
10.1.2.2 Saudi Arabia: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 Saudi Arabia: Middle East & Africa In-Vitro Lung Model Market Share - by Type
10.1.2.2.2 Saudi Arabia: Middle East & Africa In-Vitro Lung Model Market Share - by Application
10.1.2.2.3 Saudi Arabia: Middle East & Africa In-Vitro Lung Model Market Share - by End User
10.2.3.3 South Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 South Africa: Middle East & Africa In-Vitro Lung Model Market Share - by Type
10.2.3.3.2 South Africa: Middle East & Africa In-Vitro Lung Model Market Share - by Application
10.2.3.3.3 South Africa: Middle East & Africa In-Vitro Lung Model Market Share - by End User
10.3.4.4 United Arab Emirates: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 United Arab Emirates: Middle East & Africa In-Vitro Lung Model Market Share - by Type
10.3.4.4.2 United Arab Emirates: Middle East & Africa In-Vitro Lung Model Market Share - by Application
10.3.4.4.3 United Arab Emirates: Middle East & Africa In-Vitro Lung Model Market Share - by End User
10.4.5.5 Rest of Middle East & Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa In-Vitro Lung Model Market Share - by Type
10.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa In-Vitro Lung Model Market Share - by Application
10.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa In-Vitro Lung Model Market Share - by End User
11 COMPETITIVE LANDSCAPE
11. GLOBAL COMPANY MARKET SHARE ANALYSIS, 2024
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 Charles River Laboratories International Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Lonza Group AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Merck KGaA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 American Type Culture Collection (ATCC)
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Draper, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 PromoCell GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Emulate, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 MIMETAS BV
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Organovo Holdings Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 MatTek Corp
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 CN Bio Innovations Ltd
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 InSphero AG
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Epithelix
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 AlveoliX AG
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 TissUse GmbH
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
LIST OF TABLES
Table 1. Middle East & Africa In-Vitro Lung Model Market Segmentation
Table 2. List of Vendors
Table 3. Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 5. Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 6. Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. Saudi Arabia: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 9. Saudi Arabia: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. Saudi Arabia: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. South Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 12. South Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 13. South Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 14. United Arab Emirates: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 15. United Arab Emirates: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 16. United Arab Emirates: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Rest of Middle East & Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 18. Rest of Middle East & Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Rest of Middle East & Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. Heat Map Analysis by Key Players
Table 1. Middle East & Africa In-Vitro Lung Model Market Segmentation
Table 2. List of Vendors
Table 3. Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 5. Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 6. Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. Saudi Arabia: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 9. Saudi Arabia: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. Saudi Arabia: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. South Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 12. South Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 13. South Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 14. United Arab Emirates: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 15. United Arab Emirates: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 16. United Arab Emirates: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Rest of Middle East & Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 18. Rest of Middle East & Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Rest of Middle East & Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Middle East & Africa In-Vitro Lung Model Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Middle East & Africa In-Vitro Lung Model Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa In-Vitro Lung Model Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East & Africa In-Vitro Lung Model Market Share (%) - by Type, 2024 and 2031
Figure 8. 3D Model: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. 2D Model: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Middle East & Africa In-Vitro Lung Model Market Share (%) - by Application, 2024 and 2031
Figure 11. Drug Discovery and Toxicology Studies: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Physiological Research: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Regenerative Medicine: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Others: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Middle East & Africa In-Vitro Lung Model Market Share (%) - by End User, 2024 and 2031
Figure 16. Pharmaceutical and Biotechnology Companies: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Academic and Research Institutes: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Middle East & Africa In-Vitro Lung Model Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 20. Saudi Arabia: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. South Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. United Arab Emirates: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Rest of Middle East & Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Global Company Market Share Analysis, 2024
Figure 1. Middle East & Africa In-Vitro Lung Model Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Middle East & Africa In-Vitro Lung Model Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa In-Vitro Lung Model Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East & Africa In-Vitro Lung Model Market Share (%) - by Type, 2024 and 2031
Figure 8. 3D Model: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. 2D Model: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Middle East & Africa In-Vitro Lung Model Market Share (%) - by Application, 2024 and 2031
Figure 11. Drug Discovery and Toxicology Studies: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Physiological Research: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Regenerative Medicine: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Others: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Middle East & Africa In-Vitro Lung Model Market Share (%) - by End User, 2024 and 2031
Figure 16. Pharmaceutical and Biotechnology Companies: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Academic and Research Institutes: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Middle East & Africa In-Vitro Lung Model Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 20. Saudi Arabia: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. South Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. United Arab Emirates: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Rest of Middle East & Africa: Middle East & Africa In-Vitro Lung Model Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Global Company Market Share Analysis, 2024
